clinical trials

Views & Analysis

The risky and unpredictable nature of the clinical trial process is a major driver of high costs for pharmaceutical drugs.

News

The battle to develop a drug to treat Alzheimer’s disease has been dealt a blow following disappointing phase 3 trial results.

Views & Analysis

Craig Morgan outlines why comparator trials are useful and provides points to consider to ensure the best outcome.

News

Scientific and medical advances are giving the US Food and Drug Administration (FDA) more opportunities to address diseases and illness.

Partner Content

Partner Content

Humans on a chip

Events

Partner Content

Your Annual Bispecifics Meeting